Mitoxantrone in first-relapse paediatric ALL: the ALL R3 trial.
Centre of Paediatrics, University Medical Centre Schleswig-Holstein, Campus Kiel, 24105 Kiel, Germany. m.schrappe@pediatrics.uni-kiel.de
Martin
M
Schrappe
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D002648:Child; D006801:Humans; D015255:Idarubicin / Q000627:therapeutic use; D008942:Mitoxantrone / Q000627:therapeutic use*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D016032:Randomized Controlled Trials as Topic; D012008:Recurrence; D018401:Sample Size; D016896:Treatment Outcome
D000903:Antibiotics, Antineoplastic; D000970:Antineoplastic Agents; D008942:Mitoxantrone; D015255:Idarubicin